Abstract
Background: When concentrations of both reactive oxygen species and reactive nitrogen species exceed the antioxidative capability of an organism, the cells undergo oxidative impairment. Impairments in membrane integrity and lipid and protein oxidation, protein mutilation, DNA damage, and neuronal dysfunction are some of the fundamental consequences of oxidative stress. Methods: The purpose of this work was to review the associations between oxidative stress and psychological disorders. The search terms were the following: “oxidative stress and affective disorders,” “free radicals and neurodegenerative disorders,” “oxidative stress and psychological disorders,” “oxidative stress, free radicals, and psychiatric disorders,” and “association of oxidative stress.” These search terms were used in conjunction with each of the diagnostic categories of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders and World Health Organization’s International Statistical Classification of Diseases and Related Health Problems. Results: Genetic, pharmacological, biochemical, and preclinical therapeutic studies, case reports, and clinical trials were selected to explore the molecular aspects of psychological disorders that are associated with oxidative stress. We identified a broad spectrum of 83 degenerative syndromes and psychiatric disorders that were associated with oxidative stress. Conclusion: The multi-dimensional information identified herein supports the role of oxidative stress in various psychiatric disorders. We discuss the results from the perspective of developing novel therapeutic interventions.
Keywords: Oxidative stress, psychological disorders, antioxidant therapy.
Current Pharmaceutical Design
Title:Association of Oxidative Stress with Psychiatric Disorders
Volume: 22 Issue: 20
Author(s): Waseem Hassan, Hamsa Noreen, Vitor Castro-Gomes, Imdadullah Mohammadzai, Joao Batista Teixeira da Rocha and J. Landeira-Fernandez
Affiliation:
Keywords: Oxidative stress, psychological disorders, antioxidant therapy.
Abstract: Background: When concentrations of both reactive oxygen species and reactive nitrogen species exceed the antioxidative capability of an organism, the cells undergo oxidative impairment. Impairments in membrane integrity and lipid and protein oxidation, protein mutilation, DNA damage, and neuronal dysfunction are some of the fundamental consequences of oxidative stress. Methods: The purpose of this work was to review the associations between oxidative stress and psychological disorders. The search terms were the following: “oxidative stress and affective disorders,” “free radicals and neurodegenerative disorders,” “oxidative stress and psychological disorders,” “oxidative stress, free radicals, and psychiatric disorders,” and “association of oxidative stress.” These search terms were used in conjunction with each of the diagnostic categories of the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders and World Health Organization’s International Statistical Classification of Diseases and Related Health Problems. Results: Genetic, pharmacological, biochemical, and preclinical therapeutic studies, case reports, and clinical trials were selected to explore the molecular aspects of psychological disorders that are associated with oxidative stress. We identified a broad spectrum of 83 degenerative syndromes and psychiatric disorders that were associated with oxidative stress. Conclusion: The multi-dimensional information identified herein supports the role of oxidative stress in various psychiatric disorders. We discuss the results from the perspective of developing novel therapeutic interventions.
Export Options
About this article
Cite this article as:
Hassan Waseem, Noreen Hamsa, Castro-Gomes Vitor, Mohammadzai Imdadullah, Batista Teixeira da Rocha Joao and Landeira-Fernandez J., Association of Oxidative Stress with Psychiatric Disorders, Current Pharmaceutical Design 2016; 22 (20) . https://dx.doi.org/10.2174/1381612822666160307145931
DOI https://dx.doi.org/10.2174/1381612822666160307145931 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis
Current Medicinal Chemistry Morphofunctional Aspects of the Blood-Brain Barrier
Current Drug Metabolism Improvement of Microscopic MR Imaging of Amyloid Plaques with Targeting and Non-Targeting Contrast Agents
Current Medical Imaging Phytochemistry and Pharmacological Update on Tetraterpenoids
The Natural Products Journal Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline
Current Aging Science Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases
Current Drug Targets Challenges in the Discovery of Novel Therapeutic Agents for Cancer Treatment (Part IV)
Current Drug Metabolism Design and Synthesis of Dopaminergic Agonists
Current Medicinal Chemistry An Update on Peptide Drugs for Voltage-Gated Calcium Channels
Recent Patents on CNS Drug Discovery (Discontinued) NF-κB Signature on the Aging Wall
Current Drug Metabolism Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry Tetracyclines: Drugs with Huge Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Advances in Imaging Techniques of the Blood-brain Barrier and Clinical Application
Current Medical Imaging Blood Pressure and Cognitive Impairment in the Elderly
Current Hypertension Reviews A Resurrection of 7-MEOTA: A Comparison with Tacrine
Current Alzheimer Research Synthesis, Characterization and Evaluation of Gemfibrozil-Stilbene Hybrid as Antioxidant Agent
Letters in Drug Design & Discovery Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Current Molecular Pharmacology Amyloidophilic Compounds for Prion Diseases
Infectious Disorders - Drug Targets Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Pharmacophore Modeling for Antitargets
Current Topics in Medicinal Chemistry